Danco Moves To Intervene In Case That Would Scrap Abortion Pill Approval

By Beth Wang / January 17, 2023 at 4:23 PM
Danco Laboratories, manufacturer of the abortion pill Mifeprex (mifepristone), filed a motion to intervene in a lawsuit that challenges FDA’s approval of medication abortion and seeks to get the approval overturned. Danco warns that, if successful, the lawsuit would block availability of mifepristone nationwide as early as mid-February. Prescribers across the United States also would not be able to prescribe Mifeprex to their patients because the drug could not be sold or shipped to certified health care providers, the company...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.